Abstracts

PD1 Identifies Latently HIV-Infected Nonproliferating and Proliferating CD4+ T Cells

Background: CD4+ T-cells from HIV-infected individuals on antiretroviral therapy (ART) expressing the Immune Checkpoint (IC) marker of T-cell activation PD1, are preferentially infected [Chomont Nat Med 2009]. Characterizing the role of PD1 and other IC in HIV persistence during ART may identify new potential targets for eliminating latently infected T cells. Using an in vitro…

Kinetics of HIV-1 Gene Expression Following Reactivation in a Primary Cell Model of Latency

Background: CD4+ T cells latently infected with HIV-1 pose a significant barrier to eradication. Proposed “shock and kill” strategies involve using small molecules to reactivate latent HIV-1 without causing the massive toxicity associated with non-specific T cell activation. Previous work suggests that the CD8+ T cell response must be augmented in patients for this strategy…

Latent HIV-1 Reactivation and Lysosomal Destabilization Synergize to Host Cell Death

Background: Modern strategies for purging the latent HIV-1 reservoir use pharmacological reactivation followed by elimination of cells that reactivated viral latency either by the virus or/and patient’s immune system ‘shock and kill’. Unfortunately, most of the current approaches demonstrated only partial reactivation and limited reduction of the reservoir. We aimed to develop a pharmacological strategy…

Noninduced Proviral Genome Characterization in Perinatal HIV Infection

Background: The latent HIV reservoir was recently estimated as 60-times larger than previously thought due to replication-competent, non-induced proviral genomes (NIPG), creating a major impediment for cure. The frequency of circulating cells harboring proviral DNA approaches the limit of detection of ultrasensitive droplet digital PCR (ddPCR) in perinatally-infected individuals who initiated antiretroviral therapy (ART) before…

Effects of Antineoplastic Chemotherapy on Dynamics of HIV Population Genetics In Vivo

Background: HIV-1 infection is controlled, but not cured, by combination antiretroviral therapy (cART). Mechanisms of persistence are not well understood although recently a number of groups identified expanded clones of HIV infected cells with proviruses integrated in genes involved in growth promotion. Antineoplastic chemotherapy (CTX) includes agents that target proliferating cells and may therefore have…